Skip to main content

Table 1 Characteristic of patients

From: Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

 

Median

Mean

Range

Age (years)

77

76.5

53-95

Follow-up period (months)

49

52.0

12-143

PSA level at diagnosis (ng/mL)

15

28.9

1.4-200

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us